BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29083936)

  • 1. Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in Very-Elderly patients.
    Uchiwa H; Kai H; Iwamoto Y; Anegawa T; Kajimoto H; Fukuda K; Imaizumi T; Fukumoto Y;
    Clin Exp Hypertens; 2018; 40(3):267-273. PubMed ID: 29083936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
    Hanayama Y; Uchida HA; Nakamura Y; Makino H
    Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trial.
    Ueda T; Kai H; Imaizumi T;
    Hypertens Res; 2012 Jul; 35(7):708-14. PubMed ID: 22399096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of combination therapy with losartan and hydrochlorothiazide in elderly hypertension].
    Eto K; Tsuchihashi T; Abe I; Iida M
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):181-6. PubMed ID: 11974942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
    Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
    Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.
    Shiga Y; Miura S; Norimatsu K; Hitaka Y; Nagata I; Koyoshi R; Morii J; Kuwano T; Uehara Y; Inoue A; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1078-84. PubMed ID: 25143336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of losartan/hydrochlorothiazide-fixed dose combination treatment for isolated morning hypertension: The MAPPY study.
    Kai H; Ueda T; Uchiwa H; Iwamoto Y; Aoki Y; Anegawa T; Fukuda K; Fukumoto Y; Imaizumi T;
    Clin Exp Hypertens; 2015; 37(6):473-81. PubMed ID: 25816110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine.
    Shimosawa T; Gohchi K; Yatomi Y; Fujita T
    Hypertens Res; 2007 Sep; 30(9):831-7. PubMed ID: 18037776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S; Abate N; Chen E; Creager MA; Galet V; Jia G; Julius S; Lerman A; Lyle PA; Pool J; Tershakovec AM
    Curr Med Res Opin; 2008 Apr; 24(4):1101-14. PubMed ID: 18328120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
    Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
    J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
    Keating GM
    Drugs; 2009 Jun; 69(9):1239-65. PubMed ID: 19537840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
    Racine N; Hamet P; Sampalis JS; Longo N; Bastien N
    J Hum Hypertens; 2010 Nov; 24(11):739-48. PubMed ID: 20147971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.
    Miyagawa S; Yamada H; Matsubara H
    Clin Exp Hypertens; 2012; 34(6):439-46. PubMed ID: 22471874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.